The findings from the in vivo experiments involving mice indicate that the injection of CCAT2‐KO cells leads to reduced tumor volumes and masses, whereas the injection of CCAT2‐KO+OE cells results in increased tumor volumes and masses. Here, CCAT2 is linked to neoplasm.